Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Modularized Gold Nanocarriers for TAT‐Mediated Delivery of siRNA - Huang - 2017 - Small - Wiley Online Library
Nano in der Apotheke: Risiko, Perspektiven oder nur Mythos? Nano damals. pharma4u-webinar mit freundlicher Unterstützung von - PDF Free Download
Site‐Specific Labeling of MicroRNA Precursors: A Structure–Activity Relationship Study - Menzi - 2016 - ChemBioChem - Wiley Online Library
Bioengineering | Free Full-Text | Membrane Technological Pathways and Inherent Structure of Bacterial Cellulose Composites for Drug Delivery | HTML
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug | Nature Communications
Targeted Immunotherapy for Autoimmune Disease
Modularized Gold Nanocarriers for TAT‐Mediated Delivery of siRNA - Huang - 2017 - Small - Wiley Online Library
Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives | Pharmacological Reviews
Pharmaceutics | Free Full-Text | Safe and Effective Cynomolgus Monkey GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders | HTML
Neurobiologische Substrate repetitiven Verhaltens im Quinpirol Rattenmodell der Zwangsstörung FRANZISKA WIESKE 2015
PDF) Recent Heterocyclic Compounds from (1 ,3‐Dioxo‐2,3‐dihydro‐1H‐inden‐2‐ylidene)propanedinitrile
Frontiers | Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis | Cellular and Infection Microbiology
Translational drug discovery and development with the use of tissue‐relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy - Florian - 2020 - Experimental Dermatology - Wiley Online Library
Ki-67 Antibody (14-5698-82)
Ki-67 Antibody (14-5698-82)
Scaffold mediated delivery of dual miRNAs to transdifferentiate cardiac fibroblasts - ScienceDirect
IJMS | Free Full-Text | SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease | HTML
Untitled
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery | Chemical Reviews